Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion
- 1 April 1993
- journal article
- Published by Elsevier in Metabolism
- Vol. 42 (4) , 497-503
- https://doi.org/10.1016/0026-0495(93)90109-2
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Metabolism of lipoprotein remnants in humans. Studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.Journal of Clinical Investigation, 1990
- Chylomicrons and chylomicron remnants in coronary artery disease: a case-control studyAtherosclerosis, 1987
- Serum Lipemia: An Overlooked Cause of Tissue HypoxiaCardiology, 1983
- Kinetic bases of the primar hperlipidaemias: studies of apolipoprotein B turnover in geneticall defined subjectsEuropean Journal of Clinical Investigation, 1980
- Atherogenesis: a postprandial phenomenon.Circulation, 1979
- Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in ManJournal of Clinical Investigation, 1973
- Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIAJournal of Clinical Investigation, 1973
- FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASEThe Lancet, 1973